Highlights
NASDAQ: NVCR       Novocure Ltd Ord Sh
Last Price Today's Change   Day's Range   Trading Volume
128.50   +1.30 (1.02%)  126.59 - 129.65  228,732

Overview

 
Avg Volume (4 weeks):434,898
4 Weeks Range:123.20 - 143.69
4 Weeks Price Volatility (%):
25.87%
52 Weeks Range:100.13 - 232.76
52 Weeks Price Volatility (%):
21.39%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

NovoCure Ltd serves in the healthcare sector of United States. Its business involves commercial stage oncology operations involving therapies to cure critical tumors. Its key offering is the TTFields therapy, which is a low-toxicity anti-mitotic treatment that uses low-intensity, intermediate frequency, alternating electric fields to exert physical forces on molecules inside cancer cells, thereby leading to cancer cell death. NovoCure derives its major revenues in the United States, through the sale of TTFields delivery system, which includes a portable electric field generator, transducer arrays, rechargeable batteries, and accessories.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4011  5784  846  657 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 RWLK 2.59+1.29 
 SQQQ 8.13-0.02 
 LCID 26.47+2.40 
 NNVC 6.19+2.40 
 UBER 44.54+4.75 
 SPY 433.63-0.41 
 CEI 1.60+0.05 
 FAMI 0.2130.00 
 CRVS 8.53+2.36 
 UVXY 25.86-1.45